CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms
Jonathan C. Poe(Duke University), Thomas F. Tedder(Duke Medical Center), Ann S. Miller(Duke Medical Center), Cheryl B. Bock(Duke Medical Center), Yoko Fujimoto(Duke Medical Center), Minoru Hasegawa(University of Fukui), Manabu Fujimoto(Osaka Gakuin University), Karen M. Haas(Atrium Health Wake Forest Baptist), Isaac G. Sanford(Duke University)
Cited by 157
Related Papers
A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
|Immunity|2008|1.2k
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
|Journal of Clinical Investigation|2008|907
Idiopathic inflammatory myopathies
|Nature Reviews Disease Primers|2021|683
The Innate Mononuclear Phagocyte Network Depletes B Lymphocytes through Fc Receptor–dependent Mechanisms during Anti-CD20 Antibody Immunotherapy
|The Journal of Experimental Medicine|2004|631
Sequential contribution of L- and P-selectin to leukocyte rolling in vivo.
|The Journal of Experimental Medicine|1995|585